YK-11
SARM / myostatin inhibitor
Also known as YK11, yk
Half-life
~6-10 hours
What is YK-11?
Steroidal SARM that also inhibits myostatin. One of the most aggressive SARMs available.
How YK-11 works
Steroidal SARM-like compound with AR agonism and proposed myostatin suppression via follistatin signaling.
Benefits & uses
- Strong muscle-building (myostatin inhibition)
- Reputation for dramatic gains
Common uses: Extreme muscle mass, myostatin inhibition, strength.
YK-11 dosage
Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports โ dosing should be set with a qualified clinician.
- Protocol notes
- 5-15mg daily. Myostatin inhibitor + partial androgen agonist. Most suppressive SARM. Run with mini PCT.
- Commonly reported
- Observational only; experimental, minimal human dataObservational use reports โ not a recommendation.
YK-11 half-life
~6-10 hours (estimated)
YK-11 side effects
Joint pain, liver toxicity, significant suppression. Very high risk profile.
- Liver stress risk
- Hormonal suppression
- Very limited human safety data
- Strong testosterone suppression
- Possible liver stress (steroidal structure)
- Lipid shift
- Hair loss/aggression reported
Warnings & monitoring
- ๐ด Very little human data โ experimental. Requires bloodwork + medical monitoring
- Strongly suppressive โ PCT needed
- FDA-warned / WADA-banned / gray-market
- Not approved for human use
YK-11 interactions
with RAD-140
Caution ยท highYK-11 is a myostatin inhibitor with SARM properties and significant anabolic effect. Stacking with RAD-140 creates very high suppression. Exogenous testosterone as a base is strongly recommended.
Timing: Advanced-only stack; expect full suppression requiring testosterone base or PCT
with RAD-140
Caution ยท moderateYK-11 is a myostatin inhibitor with steroidal structure โ highly potent and suppressive. Combined with RAD-140, androgenic load is significant. This stack is closer to a mild steroid cycle in terms of HPTA impact.
Timing: Use low doses of each; 8-week maximum; PCT required
